Policy, Protocol and Program Delays (Full List)

Policy, Protocol and Program Delays (Full List)



In response to the COVID-19 public health emergency, we are delaying implementation of the following programs, policies, protocols and site of service reviews. Additional information and updates will be provided in future Network Bulletin editions and online at UHCprovider.com/networknews.

 

  • Commercial

 

  • Emergency Department (ED) Professional Evaluation and Management (E/M) Coding Policy focused on claims submitted with level 5 (99285) E/M code — delayed until 3rd Quarter 2020

 

 

 

 

  • Ohio — delayed until further notice
  • Washington — delayed until Sept. 1, 2020
  • Medicare Advantage

 

 

  • Commercial

 

 

  • Medical Benefit Drug Changes

 

 

 

 

 

  • Commercial and Community Plan for Texas and Pennsylvania

 

  • Orencia Step Therapy Program —no longer being implemented

 

  • Commercial

 

  • Ocrevus Step Therapy Program —no longer being implemented

 

  • Commercial and Community Plan

 

  • Ocrevus Administrative Guide/Sourcing Program — being transitioned to the Medication Sourcing Expansion (MSE) program which applies only to outpatient hospital providers —the implementation date of MSE will be announced in a future Network Bulletin.

 

  • Commercial

 

 

  • Basal insulins and other diabetic medications — delayed until July 1, 2020

 

  • Inhaled corticosteroids for asthma — no longer being implemented

 

  • Commercial

 

 

  • Commercial

 

Site of Service on some surgical codes— suspended through May 31, 2020

Site of Service surgical reviews UnitedHealthcare Oxford — delayed until July 1, 2020

 

Reference:

https://www.uhcprovider.com/en/resource-library/news/2020-network-bulletin-featured-articles/0620-policy-protocol-program-delays.html

Subscribe Our Newsletter
to get Coronavirus Updates